Henrique Rinaldi Matheus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Henrique Rinaldi Matheus has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Juliano Milanezi de Almeida
Periodontics Division, Department of Diagnostic and Surgery, School of Dentistry, São Paulo State University (UNESP), Araçatuba 16015-050, SP, Brazil
14 shared publications Edilson Ervolino
Department of Diagnostic and Surgery, Periodontics Division, School of Dentistry São Paulo State University (UNESP) Araçatuba Brazil
8 shared publicationsDavid Jonathan Rodrigues Gusman
Affiliations Periodontics Division, Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University (Unesp), Araçatuba, Brazil, School of Dentistry, Nucleus of Study and Research in Periodontics and Implantology (NEPPI), São Paulo State University (Unesp), Araçatuba, SP, Brazil
5 shared publications- Edilson Ervolino
Department of Basic Sciences, School of Dentistry, São Paulo State University (Unesp), Araçatuba 16015-050, SP, Brazil
5 shared publications - Luiz Guilherme Fiorin
Periodontics Division, Department of Diagnostic and Surgery, School of Dentistry, São Paulo State University (UNESP), Araçatuba 16015-050, SP, Brazil
5 shared publications Breno Edson Sendão Alves
Affiliations Periodontics Division, Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University (Unesp), Araçatuba, Brazil, School of Dentistry, Nucleus of Study and Research in Periodontics and Implantology (NEPPI), São Paulo State University (Unesp), Araçatuba, SP, Brazil
4 shared publications
Latest Publications
- Open Access
- 2 August 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (8) , 466
Evaluation of Systemic Lutein Supplementation on Periodontal Repair in Experimental Periodontitis in Wistar Rats
Objectives: The aim of this study was to evaluate the influence of systemic lutein (LT) supplementation on the progression of experimental periodontitis (EP) and its impact on mechanical periodontal therapy (SRP) in rats. Methods: A total of 120 male Wistar rats were used, and EP was induced by placing a ligature around the left mandibular first molar. The animals were allocated into four groups: NT (no treatment)/VEH (vehicle), NT/LT, SRP/VEH and SRP/LT. Supplementation was administered daily by oral gavage (0.7 mL/kg of vehicle or 250 mg/kg of LT). Animals were euthanized at 7, 15 and 30 days, and the hemimandibles were collected for histomorphometric analysis of the percentage of bone in the furcation region (PBF), histopathological assessment and immunohistochemical detection of inflammatory mediators (tumor necrosis factor-alpha, interleukin-1β and interleukin-10) and bone markers (tartrate-resistant acid phosphatase and osteocalcin). Results: Systemic LT supplementation, particularly when associated with scaling and root planning (SRP/LT), reduced the intensity and extent of the inflammatory infiltrate, partially decreased immunolabelling for IL-1β and TNF-α, and promoted greater organization of the connective tissue. Higher PBF values and fewer TRAP-positive cells were observed in LT-treated groups. Conclusions: Systemic LT supplementation reduced inflammation and alveolar bone resorption and enhanced the effects of mechanical periodontal therapy.
- 2 August 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (8) , 466
Open AccessEvaluation of Systemic Lutein Supplementation on Periodontal Repair in Experimental Periodontitis in Wistar Rats
Objectives: The aim of this study was to evaluate the influence of systemic lutein (LT) supplementation on the progression of experimental periodontitis (EP) and its impact on mechanical periodontal therapy (SRP) in rats. Methods: A total of 120 male Wistar rats were used, and EP was induced by placing a ligature around the left mandibular first molar. The animals were allocated into four groups: NT (no treatment)/VEH (vehicle), NT/LT, SRP/VEH and SRP/LT. Supplementation was administered daily by oral gavage (0.7 mL/kg of vehicle or 250 mg/kg of LT). Animals were euthanized at 7, 15 and 30 days, and the hemimandibles were collected for histomorphometric analysis of the percentage of bone in the furcation region (PBF), histopathological assessment and immunohistochemical detection of inflammatory mediators (tumor necrosis factor-alpha, interleukin-1β and interleukin-10) and bone markers (tartrate-resistant acid phosphatase and osteocalcin). Results: Systemic LT supplementation, particularly when associated with scaling and root planning (SRP/LT), reduced the intensity and extent of the inflammatory infiltrate, partially decreased immunolabelling for IL-1β and TNF-α, and promoted greater organization of the connective tissue. Higher PBF values and fewer TRAP-positive cells were observed in LT-treated groups. Conclusions: Systemic LT supplementation reduced inflammation and alveolar bone resorption and enhanced the effects of mechanical periodontal therapy.
- 26 May 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (5) , e70084
Calcium–Chitosan Scaffolds With Simvastatin Enhance Bone Regeneration in Critical‐Sized Calvarial Defects in Rats
Bone regeneration in critical defects remains a clinical challenge, motivating the development of biomaterials capable of supporting osteogenesis and modulating local biological responses. This study investigated the regenerative potential of chitosan–calcium (CH–Ca) scaffolds functionalized with simvastatin (SV) in rat calvarial critical‐sized defects. Forty male Wistar rats were randomly assigned to four groups ( n = 5 per group/experimental period): SHAM (coagulum), Bio‐Oss (xenograft), CH–Ca, and CH–Ca + SV. Defects of 5 mm were surgically created and filled according to group allocation. Animals were euthanized at 14 and 30 days, and samples were processed for histological, histomorphometric, Picrosirius Red, and immunohistochemical (BMP‐2 and osteocalcin [OCN]) analyses. Histologically, the SHAM group showed bone restricted to the defect margins with persistent inflammation, while Bio‐Oss exhibited partial bone extension and residual particles surrounded by connective tissue. In contrast, CH–Ca and CH–Ca + SV scaffolds supported linear bone formation progressing toward the defect center, with more pronounced mineralization in CH–Ca + SV. Histomorphometry confirmed higher new bone formation (NBF%) in CH and CH + SV compared with SHAM and Bio‐Oss at both time points, with CH + SV surpassing CH at 30 days. Picrosirius Red revealed greater collagen fiber maturation in CH + SV, whereas SHAM maintained a higher proportion of immature fibers. Immunohistochemistry demonstrated increased BMP‐2 and OCN expression in CH and CH + SV, particularly in CH + SV, at both 14 and 30 days. These findings indicate that SV‐loaded CH–Ca scaffolds enhance bone regeneration by promoting osteogenesis, collagen maturation, and the expression of osteogenic proteins, suggesting their potential as a cost‐effective and biologically favorable strategy for the treatment of critical‐sized bone defects.
- 26 May 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (5) , e70084
Calcium–Chitosan Scaffolds With Simvastatin Enhance Bone Regeneration in Critical‐Sized Calvarial Defects in Rats
Bone regeneration in critical defects remains a clinical challenge, motivating the development of biomaterials capable of supporting osteogenesis and modulating local biological responses. This study investigated the regenerative potential of chitosan–calcium (CH–Ca) scaffolds functionalized with simvastatin (SV) in rat calvarial critical‐sized defects. Forty male Wistar rats were randomly assigned to four groups ( n = 5 per group/experimental period): SHAM (coagulum), Bio‐Oss (xenograft), CH–Ca, and CH–Ca + SV. Defects of 5 mm were surgically created and filled according to group allocation. Animals were euthanized at 14 and 30 days, and samples were processed for histological, histomorphometric, Picrosirius Red, and immunohistochemical (BMP‐2 and osteocalcin [OCN]) analyses. Histologically, the SHAM group showed bone restricted to the defect margins with persistent inflammation, while Bio‐Oss exhibited partial bone extension and residual particles surrounded by connective tissue. In contrast, CH–Ca and CH–Ca + SV scaffolds supported linear bone formation progressing toward the defect center, with more pronounced mineralization in CH–Ca + SV. Histomorphometry confirmed higher new bone formation (NBF%) in CH and CH + SV compared with SHAM and Bio‐Oss at both time points, with CH + SV surpassing CH at 30 days. Picrosirius Red revealed greater collagen fiber maturation in CH + SV, whereas SHAM maintained a higher proportion of immature fibers. Immunohistochemistry demonstrated increased BMP‐2 and OCN expression in CH and CH + SV, particularly in CH + SV, at both 14 and 30 days. These findings indicate that SV‐loaded CH–Ca scaffolds enhance bone regeneration by promoting osteogenesis, collagen maturation, and the expression of osteogenic proteins, suggesting their potential as a cost‐effective and biologically favorable strategy for the treatment of critical‐sized bone defects.
- Open Access
- 1 March 2026
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (S1) , S97-S110
Implantoplasty combined with soft tissue grafting for the management of complex cases: A microsurgical approach
Background: The treatment of peri‐implantitis and/or peri‐implant soft tissue dehiscence defects (PSTD) remains challenging. The incorporation of the operating microscope (OM) into surgical procedures might have changed the treatment landscape for such conditions around implants. The aim of this case series is to present three clinical cases in which the combination of connective tissue grafting (CTG) and implantoplasty was performed under microscopy and served as the key tools for managing complex cases. Methods: In this article, the authors illustrate three distinct cases in which the combination of CTG and implantoplasty was used as a single or double‐staged approach for the treatment of PSTD, combined or not with peri‐implantitis. Importantly, the OM was used as a critical tool to increase precision and reduce trauma. Results: Overall, all procedures successfully preserved implants up to 3 years in highly compromised conditions. The approaches achieved a reduction in mucosal recession of up to 2 mm and successfully increased the thickness of the soft tissues. In addition to the maximum precision combined with the lesser trauma, the OM was critical for allowing delicate flap elevation of extremely thin tissues, achieving the smoothest implant surface with minimal wear, and permitting intimate adaptation of the CTG to the recipient bed. Conclusion: The OM combined with advanced skills for surgeons facilitated critical steps of the surgical procedures. Microsurgery combined with implantoplasty and connective tissue grafting offers an effective alternative for managing supraosseous or exposed implant threads caused by peri‐implant disease or poor implant positioning. Key points: Limited evidence supports implantoplasty with connective tissue grafting for complex implant complications, especially in esthetic areas. This case series shows implantoplasty aids decontamination and also reduces buccal implant volume, while connective tissue grafting enhances peri‐implant soft tissue thickness. The microsurgical approach was fundamental to treatment success. It improved precision, minimized trauma, and promoted better healing and lower morbidity. Plain language summary: This group of cases shows that using a combination of implant surface polishing (implantoplasty) and soft tissue grafts, done with a precise microsurgical technique, can be an effective and less invasive way to treat complicated cases, without needing to remove the implant.
- 1 March 2026
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (S1) , S97-S110
Open AccessImplantoplasty combined with soft tissue grafting for the management of complex cases: A microsurgical approach
Background: The treatment of peri‐implantitis and/or peri‐implant soft tissue dehiscence defects (PSTD) remains challenging. The incorporation of the operating microscope (OM) into surgical procedures might have changed the treatment landscape for such conditions around implants. The aim of this case series is to present three clinical cases in which the combination of connective tissue grafting (CTG) and implantoplasty was performed under microscopy and served as the key tools for managing complex cases. Methods: In this article, the authors illustrate three distinct cases in which the combination of CTG and implantoplasty was used as a single or double‐staged approach for the treatment of PSTD, combined or not with peri‐implantitis. Importantly, the OM was used as a critical tool to increase precision and reduce trauma. Results: Overall, all procedures successfully preserved implants up to 3 years in highly compromised conditions. The approaches achieved a reduction in mucosal recession of up to 2 mm and successfully increased the thickness of the soft tissues. In addition to the maximum precision combined with the lesser trauma, the OM was critical for allowing delicate flap elevation of extremely thin tissues, achieving the smoothest implant surface with minimal wear, and permitting intimate adaptation of the CTG to the recipient bed. Conclusion: The OM combined with advanced skills for surgeons facilitated critical steps of the surgical procedures. Microsurgery combined with implantoplasty and connective tissue grafting offers an effective alternative for managing supraosseous or exposed implant threads caused by peri‐implant disease or poor implant positioning. Key points: Limited evidence supports implantoplasty with connective tissue grafting for complex implant complications, especially in esthetic areas. This case series shows implantoplasty aids decontamination and also reduces buccal implant volume, while connective tissue grafting enhances peri‐implant soft tissue thickness. The microsurgical approach was fundamental to treatment success. It improved precision, minimized trauma, and promoted better healing and lower morbidity. Plain language summary: This group of cases shows that using a combination of implant surface polishing (implantoplasty) and soft tissue grafts, done with a precise microsurgical technique, can be an effective and less invasive way to treat complicated cases, without needing to remove the implant.
- 19 February 2026
- Published by Wiley in Journal of Periodontology
- Vol. 97 (9) , 1949-1964
Effects of cisplatin and tamoxifen chemotherapy on peri‐implant bone remodeling around titanium implants in ovariectomized rats: An in vivo study
Background: The proposition of the present study was to evaluate the influence of the secondary effect of tamoxifen (TAM) associated with cisplatin (CIS) in the bone remodeling of osseointegrated titanium implants installed in rat tibiae. Methods: One hundred female rats underwent bilateral ovariectomy (OVX) and received titanium implants in both tibiae. Six weeks later, animals were treated with tamoxifen (15 mg/kg) or saline, with further subdivisions receiving cisplatin (5 mg/kg or 2.5 mg/kg) or saline. A non‐ovariectomized group served as a negative control. Animals were euthanized at 30 and 90 days after treatment initiation. Tibiae were harvested for histometric analysis of bone‐to‐implant contact (BIC) and bone ingrowth (BIN), histology, and immunohistochemistry (tartrate‐resistant acid phosphatase [TRAP], osteocalcin [OCN], and runt‐related transcription factor [RUNX2]). Additionally, scanning electron microscopy (SEM) and energy‐dispersive X‐ray spectroscopy (EDS) were used for ultrastructural and elemental analyses. Results: The groups that received TAM showed higher BIC and BIN, increased expression of RUNX‐2 and OCN, and a lower number of TRAP‐positive cells. At 30 and 90 days, almost all spaces were filled with vital, well‐vascularized bone tissue without inflammatory foci. TAM groups also exhibited an increased calcium/phosphate (Ca/P) ratio compared to their respective controls, and a progressive thickening of collagen fibril bundles was observed in the bone matrix. Conclusion: Tamoxifen positively influenced bone remodeling around osseointegrated titanium implants in rats undergoing cisplatin‐based cancer therapy. Plain Language Summary: Dental implant surgery in patients undergoing chemotherapy is frequently approached with caution, as these pharmacological treatments can impair bone metabolism and jeopardize the integration of the implant with the bone. This study investigated whether tamoxifen, a medication widely utilized in breast cancer therapy, could potentially enhance bone healing around titanium implants, specifically when administered alongside the chemotherapeutic agent cisplatin. Utilizing a laboratory model that simulates postmenopausal bone loss, the research demonstrated that tamoxifen significantly improved both the volume and the structural quality of the bone surrounding the implants, partially mitigating the adverse effects associated with cisplatin. These findings are of clinical importance as they suggest that a history of chemotherapy should not be considered a definitive barrier to successful dental rehabilitation. Instead, with appropriate pharmacological support, dental implant procedures may be a more viable and predictable treatment option for cancer survivors than previously recognized. This research provides a foundation for clinicians to better evaluate the feasibility of oral rehabilitation in this patient population, ultimately aiming to improve their long‐term oral health and quality of life.
- 19 February 2026
- Published by Wiley in Journal of Periodontology
- Vol. 97 (9) , 1949-1964
Effects of cisplatin and tamoxifen chemotherapy on peri‐implant bone remodeling around titanium implants in ovariectomized rats: An in vivo study
Background: The proposition of the present study was to evaluate the influence of the secondary effect of tamoxifen (TAM) associated with cisplatin (CIS) in the bone remodeling of osseointegrated titanium implants installed in rat tibiae. Methods: One hundred female rats underwent bilateral ovariectomy (OVX) and received titanium implants in both tibiae. Six weeks later, animals were treated with tamoxifen (15 mg/kg) or saline, with further subdivisions receiving cisplatin (5 mg/kg or 2.5 mg/kg) or saline. A non‐ovariectomized group served as a negative control. Animals were euthanized at 30 and 90 days after treatment initiation. Tibiae were harvested for histometric analysis of bone‐to‐implant contact (BIC) and bone ingrowth (BIN), histology, and immunohistochemistry (tartrate‐resistant acid phosphatase [TRAP], osteocalcin [OCN], and runt‐related transcription factor [RUNX2]). Additionally, scanning electron microscopy (SEM) and energy‐dispersive X‐ray spectroscopy (EDS) were used for ultrastructural and elemental analyses. Results: The groups that received TAM showed higher BIC and BIN, increased expression of RUNX‐2 and OCN, and a lower number of TRAP‐positive cells. At 30 and 90 days, almost all spaces were filled with vital, well‐vascularized bone tissue without inflammatory foci. TAM groups also exhibited an increased calcium/phosphate (Ca/P) ratio compared to their respective controls, and a progressive thickening of collagen fibril bundles was observed in the bone matrix. Conclusion: Tamoxifen positively influenced bone remodeling around osseointegrated titanium implants in rats undergoing cisplatin‐based cancer therapy. Plain Language Summary: Dental implant surgery in patients undergoing chemotherapy is frequently approached with caution, as these pharmacological treatments can impair bone metabolism and jeopardize the integration of the implant with the bone. This study investigated whether tamoxifen, a medication widely utilized in breast cancer therapy, could potentially enhance bone healing around titanium implants, specifically when administered alongside the chemotherapeutic agent cisplatin. Utilizing a laboratory model that simulates postmenopausal bone loss, the research demonstrated that tamoxifen significantly improved both the volume and the structural quality of the bone surrounding the implants, partially mitigating the adverse effects associated with cisplatin. These findings are of clinical importance as they suggest that a history of chemotherapy should not be considered a definitive barrier to successful dental rehabilitation. Instead, with appropriate pharmacological support, dental implant procedures may be a more viable and predictable treatment option for cancer survivors than previously recognized. This research provides a foundation for clinicians to better evaluate the feasibility of oral rehabilitation in this patient population, ultimately aiming to improve their long‐term oral health and quality of life.
- 17 July 2025
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (1) , 144-152
Root coverage in deep recessions with apex involvement: Long‐term case study
Background: Teeth with deep gingival recessions (GRs) associated with apex exposure present a challenging clinical scenario, often requiring a multidisciplinary approach to improve tooth prognosis. This case study presents seven RT1/RT2 deep GR (≥5 mm) associated with root apex exposure, treated with endodontic treatment, apicoectomy, and root coverage procedures. Methods: For this retrospective study, all surgical procedures were performed using either the laterally positioned flap technique or the modified double papilla flap combined with a connective tissue graft (CTG). Results: After a mean follow‐up period of 3.86 years (ranging from 1 to 11 years), a mean GR reduction of 7.57 mm was observed, with four cases achieving complete root coverage. No teeth required extraction during the follow‐up period and the prognosis for all teeth was improved. Conclusion: This case study highlights the effectiveness of treating teeth with severe mucogingival defects through root coverage surgery combined with CTG and apicoectomy. Key points: Mucogingival procedures and interdisciplinary treatment can successfully change the tooth prognosis. Currently, there is limited information on managing teeth with a deep recession and apex involvement and even less on long‐term outcomes for these cases. This case study fills these gaps, demonstrating that root coverage using an autogenous connective tissue graft combined with apicoectomy can yield successful and stable outcomes. Clinicians might consider the lateral‐positioned flap or the modified double papilla flap, both of which may require specialized training and experience. However, other treatment alternatives, such as extraction and subsequent hard—and soft‐tissue reconstruction, would involve more surgical procedures to rebuild all the lost tissues, increasing treatment complexity, time, and morbidity. Thus, mucogingival treatment should be prioritized as the first‐line approach. Plain language summary: This study showed that teeth with severe gum recession, reaching the tip of the root, can be successfully treated with surgery to cover the exposed root, combined with tissue grafting and a procedure to remove the root tip. These treatments provided long‐lasting results.
- 17 July 2025
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (1) , 144-152
Root coverage in deep recessions with apex involvement: Long‐term case study
Background: Teeth with deep gingival recessions (GRs) associated with apex exposure present a challenging clinical scenario, often requiring a multidisciplinary approach to improve tooth prognosis. This case study presents seven RT1/RT2 deep GR (≥5 mm) associated with root apex exposure, treated with endodontic treatment, apicoectomy, and root coverage procedures. Methods: For this retrospective study, all surgical procedures were performed using either the laterally positioned flap technique or the modified double papilla flap combined with a connective tissue graft (CTG). Results: After a mean follow‐up period of 3.86 years (ranging from 1 to 11 years), a mean GR reduction of 7.57 mm was observed, with four cases achieving complete root coverage. No teeth required extraction during the follow‐up period and the prognosis for all teeth was improved. Conclusion: This case study highlights the effectiveness of treating teeth with severe mucogingival defects through root coverage surgery combined with CTG and apicoectomy. Key points: Mucogingival procedures and interdisciplinary treatment can successfully change the tooth prognosis. Currently, there is limited information on managing teeth with a deep recession and apex involvement and even less on long‐term outcomes for these cases. This case study fills these gaps, demonstrating that root coverage using an autogenous connective tissue graft combined with apicoectomy can yield successful and stable outcomes. Clinicians might consider the lateral‐positioned flap or the modified double papilla flap, both of which may require specialized training and experience. However, other treatment alternatives, such as extraction and subsequent hard—and soft‐tissue reconstruction, would involve more surgical procedures to rebuild all the lost tissues, increasing treatment complexity, time, and morbidity. Thus, mucogingival treatment should be prioritized as the first‐line approach. Plain language summary: This study showed that teeth with severe gum recession, reaching the tip of the root, can be successfully treated with surgery to cover the exposed root, combined with tissue grafting and a procedure to remove the root tip. These treatments provided long‐lasting results.
- Open Access
- 26 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320413
Omega-3 attenuates the severity of medication-related osteonecrosis of the jaws in rats treated with zoledronate
This study aimed to evaluate the ability of ω-3 to modulate the tissue response in rats with MRONJ, focusing on histopathological and immunohistochemical parameters. Forty Wistar rats were subjected to bilateral ovariectomy and, three months later, the medication regimen with ZOL (100μg/kg; groups ZOL and ZOL-ω3) of vehicle (VEH and VEH-ω3) was initiated. Following 3 weeks of ZOL or VEH, experimental periodontitis was induced around the mandibular left first molars of all animals. Then, 14 days later (one day before tooth extraction), daily dietary supplementation with ω-3 was given to animals belonging to groups VEH-ω3 or ZOL-ω3. Euthanasia was performed 21 days after tooth extraction. Histologic, histometric (newly-formed bone tissue [NFBT] and non-vital bone tissue [NVBT]), and immunohistochemical (TNF-α, α-SMA, ALP, IL-1β, VEGF, OCN, and TRAP) analyses were performed. Dietary supplementation with ω-3 reduced the amount of NVBT and controlled the intensity and extension of the inflammatory infiltrate in ZOL-ω3, as compared with ZOL. Osteoclast and osteoblast activity were not statistically different between groups ZOL and ZOL-ω3. The structure of the epithelium and the underlining connective tissue were improved by the supplementation with ω-3 in animals under ZOL therapy. Oral supplementation with omega-3 controlled the inflammation and reduced the amount of non-vital bone at the tooth extraction site of ovariectomized rats treated with ZOL and attenuating the severity of MRONJ.
- 26 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320413
Open AccessOmega-3 attenuates the severity of medication-related osteonecrosis of the jaws in rats treated with zoledronate
This study aimed to evaluate the ability of ω-3 to modulate the tissue response in rats with MRONJ, focusing on histopathological and immunohistochemical parameters. Forty Wistar rats were subjected to bilateral ovariectomy and, three months later, the medication regimen with ZOL (100μg/kg; groups ZOL and ZOL-ω3) of vehicle (VEH and VEH-ω3) was initiated. Following 3 weeks of ZOL or VEH, experimental periodontitis was induced around the mandibular left first molars of all animals. Then, 14 days later (one day before tooth extraction), daily dietary supplementation with ω-3 was given to animals belonging to groups VEH-ω3 or ZOL-ω3. Euthanasia was performed 21 days after tooth extraction. Histologic, histometric (newly-formed bone tissue [NFBT] and non-vital bone tissue [NVBT]), and immunohistochemical (TNF-α, α-SMA, ALP, IL-1β, VEGF, OCN, and TRAP) analyses were performed. Dietary supplementation with ω-3 reduced the amount of NVBT and controlled the intensity and extension of the inflammatory infiltrate in ZOL-ω3, as compared with ZOL. Osteoclast and osteoblast activity were not statistically different between groups ZOL and ZOL-ω3. The structure of the epithelium and the underlining connective tissue were improved by the supplementation with ω-3 in animals under ZOL therapy. Oral supplementation with omega-3 controlled the inflammation and reduced the amount of non-vital bone at the tooth extraction site of ovariectomized rats treated with ZOL and attenuating the severity of MRONJ.
- Open Access
- 3 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0315462
Effect of coenzyme Q10 on tibial fracture resistance in nicotine-exposed rats
The study aimed to evaluate the potential protection against fractures of oral Q10 supplementation in the tibias of rats exposed to nicotine. Nicotine is known to negatively impact bone density and increase the risk of fractures, in addition to affecting other systems such as the gastrointestinal system, impairing its absorption capacity, negatively affecting bone health. To investigate this, eighty male rats were divided into four groups (n = 20) receiving either nicotine hemisulfate or saline solution (SS) for 28 days. Two daily subcutaneous applications were administered accordingly. Concurrently, vegetable glycerin and Q10 gavage began on day "0". SS: the animals in this group received two daily subcutaneous applications of sodium chloride solution during the entire trial period. 30 days after starting the SS applications subcutaneously, the animals received vegetable glycerin daily until the end of the experiment. SS-Q10: the animals received the SS protocol and daily supplementation with Q10 until the end of the experiment. NIC: The animals received the protocol for NIC and vegetable glycerin daily until the end of the experiment. NIC-Q10: The animals received the protocol for NIC and daily supplementation and Q10 until the end of the experiment. Euthanasia occurred at 7 and 28 days after the beginning the gavage. The tibiae collected were processed for morphometric, densitometric, mechanical, and microtomographic (micro-Ct) analysis. A complementary analysis of intestinal changes was performed. The groups that received Q10 showed slightly better results regarding the mechanical resistance and micro-Ct parameters and to intestinal histomorphometry, as compared with groups not supplemented with Q10. Thus, in rats, it can be concluded that coenzyme Q10 exhibited a protective property to the skeletal system and the gastrointestinal tract, even in the presence of nicotine.
- 3 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0315462
Open AccessEffect of coenzyme Q10 on tibial fracture resistance in nicotine-exposed rats
The study aimed to evaluate the potential protection against fractures of oral Q10 supplementation in the tibias of rats exposed to nicotine. Nicotine is known to negatively impact bone density and increase the risk of fractures, in addition to affecting other systems such as the gastrointestinal system, impairing its absorption capacity, negatively affecting bone health. To investigate this, eighty male rats were divided into four groups (n = 20) receiving either nicotine hemisulfate or saline solution (SS) for 28 days. Two daily subcutaneous applications were administered accordingly. Concurrently, vegetable glycerin and Q10 gavage began on day "0". SS: the animals in this group received two daily subcutaneous applications of sodium chloride solution during the entire trial period. 30 days after starting the SS applications subcutaneously, the animals received vegetable glycerin daily until the end of the experiment. SS-Q10: the animals received the SS protocol and daily supplementation with Q10 until the end of the experiment. NIC: The animals received the protocol for NIC and vegetable glycerin daily until the end of the experiment. NIC-Q10: The animals received the protocol for NIC and daily supplementation and Q10 until the end of the experiment. Euthanasia occurred at 7 and 28 days after the beginning the gavage. The tibiae collected were processed for morphometric, densitometric, mechanical, and microtomographic (micro-Ct) analysis. A complementary analysis of intestinal changes was performed. The groups that received Q10 showed slightly better results regarding the mechanical resistance and micro-Ct parameters and to intestinal histomorphometry, as compared with groups not supplemented with Q10. Thus, in rats, it can be concluded that coenzyme Q10 exhibited a protective property to the skeletal system and the gastrointestinal tract, even in the presence of nicotine.
- 26 December 2023
- Published by Elsevier in Archives of Oral Biology
- Vol. 159, 105875
Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes
- 26 December 2023
- Published by Elsevier in Archives of Oral Biology
- Vol. 159, 105875
Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes
- 20 July 2022
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (4) , 880-890
Tamoxifen improves homeostasis in the peri‐implant bone remodeling of osseointegrated titanium implants
Background: The purpose of this preclinical study was to evaluate the influence of tamoxifen (TAM) on the peri‐implant bone remodeling of osseointegrated titanium implants in ovariectomized female rats.Materials and Methods: Seventy‐two female rats underwent bilateral ovariectomy 20 weeks before implants placement. One titanium implant was inserted in each tibia of the animals. Six weeks following the implant surgery, animals were randomly divided into two experimental groups (n = 36), which received either saline solution (SS) or tamoxifen citrate (TAM) via gavage until euthanasia. Euthanasia was performed at 30, 60, and 90 days after the first gavage. Assessments of bone to implant contact (BIC), bone ingrowth percentage (BIN), morphological description of cellular and tissue reactions, immunohistochemistry for the detection of bone morphogenetic protein 2/4 (BMP2/4), runt‐related transcription factor 2 (RUNX‐2), osteocalcin (OCN) and tartrate‐resistant acid phosphatase (TRAP), and bone chemical composition through scanning electron microscopy with energy‐dispersive x‐ray spectroscopy were performed.Results: Tamoxifen group presented higher BIC, higher BIN, higher RUNX‐2 and OCN, lower TRAP‐positive cells/mm2, and no differences regarding BMP‐2/4 positive cells/mm2 than SS group in all periods. TAM group also showed higher Ca/P rate than SS group.Conclusion: Tamoxifen enhanced the remodeling of the bone surrounding titanium implants in ovariectomized rats.
- 20 July 2022
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (4) , 880-890
Tamoxifen improves homeostasis in the peri‐implant bone remodeling of osseointegrated titanium implants
Background: The purpose of this preclinical study was to evaluate the influence of tamoxifen (TAM) on the peri‐implant bone remodeling of osseointegrated titanium implants in ovariectomized female rats.Materials and Methods: Seventy‐two female rats underwent bilateral ovariectomy 20 weeks before implants placement. One titanium implant was inserted in each tibia of the animals. Six weeks following the implant surgery, animals were randomly divided into two experimental groups (n = 36), which received either saline solution (SS) or tamoxifen citrate (TAM) via gavage until euthanasia. Euthanasia was performed at 30, 60, and 90 days after the first gavage. Assessments of bone to implant contact (BIC), bone ingrowth percentage (BIN), morphological description of cellular and tissue reactions, immunohistochemistry for the detection of bone morphogenetic protein 2/4 (BMP2/4), runt‐related transcription factor 2 (RUNX‐2), osteocalcin (OCN) and tartrate‐resistant acid phosphatase (TRAP), and bone chemical composition through scanning electron microscopy with energy‐dispersive x‐ray spectroscopy were performed.Results: Tamoxifen group presented higher BIC, higher BIN, higher RUNX‐2 and OCN, lower TRAP‐positive cells/mm2, and no differences regarding BMP‐2/4 positive cells/mm2 than SS group in all periods. TAM group also showed higher Ca/P rate than SS group.Conclusion: Tamoxifen enhanced the remodeling of the bone surrounding titanium implants in ovariectomized rats.
- 18 May 2022
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 30 (9) , 1174-1185
Stem cell-based therapies for temporomandibular joint osteoarthritis and regeneration of cartilage/osteochondral defects: a systematic review of preclinical experiments
- 18 May 2022
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 30 (9) , 1174-1185
Stem cell-based therapies for temporomandibular joint osteoarthritis and regeneration of cartilage/osteochondral defects: a systematic review of preclinical experiments